###begin article-title 0
###xml 42 47 <span type="species:ncbi:9606">Human</span>
Determination of Cellular Lipids Bound to Human CD1d Molecules
###end article-title 0
###begin p 1
Conceived and designed the experiments: DGC JEG WH. Performed the experiments: DGC. Analyzed the data: DGC. Contributed reagents/materials/analysis tools: DGC LMF RT WB MS DM JEG WH. Wrote the paper: DGC JEG WH.
###end p 1
###begin p 2
###xml 407 412 <span type="species:ncbi:9606">human</span>
###xml 967 972 <span type="species:ncbi:9606">human</span>
CD1 molecules are glycoproteins that present lipid antigens at the cell surface for immunological recognition by specialized populations of T lymphocytes. Prior experimental data suggest a wide variety of lipid species can bind to CD1 molecules, but little is known about the characteristics of cellular ligands that are selected for presentation. Here we have molecularly characterized lipids bound to the human CD1d isoform. Ligands were eluted from secreted CD1d molecules and separated by normal phase HPLC, then characterized by mass spectroscopy. A total of 177 lipid species were molecularly identified, comprising glycerophospholipids and sphingolipids. The glycerophospholipids included common diacylglycerol species, reduced forms known as plasmalogens, lyso-phospholipids (monoacyl species), and cardiolipins (tetraacyl species). The sphingolipids included sphingomyelins and glycosylated forms, such as the ganglioside GM3. These results demonstrate that human CD1d molecules bind a surprising diversity of lipid structures within the secretory pathway, including compounds that have been reported to play roles in cancer, autoimmune diseases, lipid signaling, and cell death.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 34 35 31 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 164 167 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Brigl1">[1]</xref>
###xml 447 450 444 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Bendelac1">[2]</xref>
###xml 615 618 612 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Bendelac1">[2]</xref>
###xml 659 664 <span type="species:ncbi:9606">human</span>
CD1 molecules are a family of beta2-microglobulin associated glycoproteins that present lipids and glycolipids at the cell surface for recognition by T lymphocytes [1]. There are five CD1 isoforms (CD1a, CD1b, CD1c, CD1d, and CD1e). Of these, the CD1d isoform has attracted particular attention because it is the restricting element for a subpopulation of T cells, called Natural Killer T (NKT) cells, that has potent immuno-modulatory properties [2]. In addition to recognizing certain microbial lipids, NKT cells have been found to respond specifically to CD1d-mediated presentation of endogenous cellular lipids [2]. However, the self lipids recognized by human NKT cells remain poorly characterized. Similarly, the molecular principles that govern the selection of lipids that are presented by CD1d molecules for immunological surveillance are not well understood.
###end p 4
###begin p 5
###xml 208 211 208 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Zajonc1">[3]</xref>
###xml 212 215 212 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Zajonc4">[8]</xref>
###xml 340 343 332 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Koch1">[9]</xref>
###xml 22 28 <span type="species:ncbi:10090">murine</span>
###xml 217 222 <span type="species:ncbi:9606">Human</span>
Crystal structures of murine CD1d have been solved with a variety of bound ligands, including glycosylated sphingolipids (GSLs), phosphatidylcholine (PC), and a mannosylated form of phosphatidylinositol (PI) [3]-[8]. Human CD1d molecules have been crystallized bound to the glycosylated sphingolipid alpha-galactosylceramide (alpha-GalCer) [9]. These analyses have revealed that CD1d molecules have an overall structure resembling MHC class I, but that their ligand binding groove is deeper and more hydrophobic. Lipid ligands bind to CD1d with their hydrophobic carbon chains largely buried within the binding groove, and their polar head groups accessible at the molecular surface. The crystal structures indicate there is some hydrogen bonding between the CD1d molecule and features of the polar head groups of bound ligands, however, it is not clear how much selection is exerted by the CD1d molecule on the chemical nature of the ligand's head group. Nevertheless, it is clear from the crystallographic data that a wide variety of polar head group structures can be accommodated.
###end p 5
###begin p 6
###xml 192 195 192 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Koch1">[9]</xref>
###xml 225 228 225 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Zajonc1">[3]</xref>
###xml 772 776 772 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Im1">[10]</xref>
###xml 777 781 777 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Miyamoto1">[13]</xref>
###xml 1067 1071 1067 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-McCarthy1">[11]</xref>
###xml 1291 1295 1291 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Miyamoto1">[13]</xref>
###xml 1297 1301 1297 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Goff1">[14]</xref>
###xml 181 186 <span type="species:ncbi:9606">human</span>
###xml 213 219 <span type="species:ncbi:10090">murine</span>
###xml 1006 1011 <span type="species:ncbi:9606">human</span>
In contrast, hydrocarbon chains of bound lipids usually fit snugly within the hydrophobic binding site. The CD1d ligand binding site contains two major pockets, named A' and C' for human CD1d [9] or A' and F' for murine CD1d [3], with the A' pocket able to accommodate somewhat longer hydrocarbon chains (approximately 26 carbons) than the C'/F' pocket (approximately 18 carbons). The crystallographic data suggest that hydrocarbon chains containing multiple double bonds bind preferentially in the A' pocket where they can adopt a curved conformation, whereas the C'/F' pocket provides a more linear configuration. However, biochemical analyses indicate that CD1d molecules can bind a diverse array of ligands that include substantial variation in radyl group structures [10]-[13]. The stability of lipid binding to CD1d molecules has been related to the length of the hydrocarbon chains and the manner in which they fill the binding groove, with longer chains that fit well into the A' and C' pockets of human CD1d providing for increased half-lives of association [11]. Nevertheless, it is important to note that antigenic lipids in which one of the hydrocarbon chains is severely truncated can still bind to CD1d molecules in a sufficiently stable manner to stimulate NKT cell responses [13], [14].
###end p 6
###begin p 7
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-DeSilva1">[15]</xref>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Joyce1">[16]</xref>
###xml 311 314 311 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Giabbai1">[7]</xref>
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Park1">[17]</xref>
###xml 668 672 668 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Gumperz1">[18]</xref>
###xml 673 677 673 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Agea1">[20]</xref>
###xml 995 999 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Zhou1">[21]</xref>
###xml 1139 1143 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Christiansen1">[22]</xref>
###xml 132 138 <span type="species:ncbi:10090">murine</span>
###xml 187 193 <span type="species:ncbi:10090">murine</span>
###xml 342 347 <span type="species:ncbi:9606">human</span>
###xml 457 463 <span type="species:ncbi:10090">murine</span>
###xml 468 473 <span type="species:ncbi:9606">human</span>
###xml 697 703 <span type="species:ncbi:10090">murine</span>
###xml 1057 1062 <span type="species:ncbi:9606">human</span>
###xml 1079 1085 <span type="species:ncbi:9606">humans</span>
###xml 1207 1212 <span type="species:ncbi:9606">human</span>
###xml 1297 1302 <span type="species:ncbi:9606">human</span>
###xml 1376 1381 <span type="species:ncbi:9606">human</span>
###xml 1455 1460 <span type="species:ncbi:9606">human</span>
Previous studies have identified glycosylated phosphatidylinositols (GPIs) and unmodified PI as major mammalian cellular ligands of murine CD1d molecules [15], [16]. Material eluted from murine CD1d molecules that were purified from transfected insect cells included mainly PC and phosphatidylethanolamine (PE) [7]. Cellular ligands bound to human CD1d molecules included PI molecules with a variety of acyl chain structures [17]. However, while individual murine and human NKT cells have been identified that specifically recognize phospholipids such as PI and PE as antigens presented by CD1d, NKT cells that recognize these abundant phospholipids appear to be rare [18]-[20]. In contrast, most murine NKT cells recognize a particular tri-glycosylated sphingolipid called isoglobotrihexosylceramide (iGb3), which may be a much less abundant component of the pool of lipids presented by CD1d molecules since it is produced in lysosomes by degradation of a mature form that contains four sugars [21]. It is not clear whether iGb3 is also a self antigen for human NKT cells since humans lack the enzyme required to synthesize this compound [22], however it seems likely that the self antigens that stimulate human NKT cells may also be minor components of the pool of cellular ligands presented by human CD1d molecules. Thus, a high-resolution analysis of the ligands bound to human CD1d is critical for identifying compounds of interest that may regulate human NKT cell responses. Additionally, such an analysis would provide information about the structural characteristics of lipid species that are naturally selected for binding by CD1d. This information will be key for designing new compounds that can be used therapeutically to modulate immune responses by stimulating NKT cells, since such pharmacological lipid antigens will need to be able to compete effectively with endogenous lipids for binding to CD1d molecules on antigen presenting cells.
###end p 7
###begin title 8
Results
###end title 8
###begin p 9
###xml 197 201 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Shimizu1">[23]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Prilliman1">[24]</xref>
###xml 515 519 515 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Bligh1">[25]</xref>
###xml 668 677 668 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g001">Figure 1A</xref>
###xml 856 865 856 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g001">Figure 1B</xref>
###xml 1128 1145 1128 1145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g001">Figures 1C and 1D</xref>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
Secreted human CD1d molecules (sCD1d) were generated by truncating the transmembrane and cytoplasmic domains, and were expressed in the HLA class I deficient human lymphoblastoid cell line 721.221 [23], [24]. The cells were grown in hollow-fiber bioreactors and approximately 25 mg of sCD1d was purified by affinity chromatography. Bound ligands were released and separated from the sCD1d molecules by employing a chloroform:methanol:water extraction protocol similar to that previously described by Bligh and Dyer [25]. The eluted material was further purified by normal phase HPLC, resulting in the fractionation of various classes of lipids within the ligand pool (Figure 1A). Fractions from the HPLC purification were subject to mass spectrometry (MS) in both positive and negative ion modes, generating ion maps of the compounds within each fraction (Figure 1B). Individual ion peaks from these maps were further analyzed by MS/MS, producing fragmentation patterns that allowed structural identification of the major species in the peak by comparison to previously published data and analysis of synthetic lipid standards (Figures 1C and 1D).
###end p 9
###begin title 10
###xml 51 56 <span type="species:ncbi:9606">human</span>
Isolation and characterization of ligands bound to human CD1d molecules.
###end title 10
###begin p 11
###xml 872 873 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 874 875 874 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 890 891 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 917 918 917 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 919 920 919 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 931 933 931 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 934 936 934 936 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sub>
###xml 947 948 947 948 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 980 981 980 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 982 983 982 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 994 996 994 996 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sub>
###xml 997 999 997 999 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sub>
###xml 1001 1002 1001 1002 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1004 1005 1004 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1046 1047 1046 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1048 1049 1048 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1060 1062 1060 1062 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 1063 1065 1063 1065 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sub>
###xml 1080 1081 1080 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1126 1127 1126 1127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1128 1129 1128 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1136 1138 1136 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sub>
###xml 1139 1141 1139 1141 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sub>
###xml 1143 1144 1143 1144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1145 1146 1145 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1167 1168 1167 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1169 1170 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1182 1183 1182 1183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1185 1186 1185 1186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1188 1189 1188 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Secreted CD1d molecules were isolated by affinity chromatography and subject to organic extraction followed normal phase chromatographic separation (HPLC), and mass spectrometry (MS). A) HPLC chromatogram of extracted material. The general categories of lipids found along the profile are indicated using the following abbreviations: GSL, glycosphingolipid; PE, phosphatidylethanolamine; CL, cardiolipin; PA, phosphatidic acid; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine; GM3, ganglioside GM3; PC, phosphatidylcholine; SM, sphingomeylin. B) A section of MS ion map of fraction 26 in the negative ion mode. Ions were manually selected for MS/MS fragmentation. Within this section of the ion map three lipids were characterized, as shown by the labels above the corresponding peaks. C) MS/MS fragmentation pattern of one of these lipids, ion m/z 861. The [M-H]- of ion 861 provides ions m/z 597 [M-H-C16H31CH = C = O]- (the loss of the 18:1 ketene), m/z 579 [M-H-C17H33CO2H]- (the loss of the 18:1 carboxylic acid), m/z 417 [M-H-C16H31CH = C = O-Ins]- (the loss of the 18:1 ketene and inositol), m/z 281 [C17H33CO2]-, (18:1 fatty acid), m/z 241 [Ins-PO3-H2O]- (dehydrated inositol phosphate). D) MS/MS fragmentation pattern of synthetic PI (18:1/18:1).
###end p 11
###begin title 12
Types of lipids bound by CD1d
###end title 12
###begin p 13
###xml 302 310 302 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g002">Figure 2</xref>
###xml 561 570 561 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g002">Figure 2A</xref>
###xml 698 707 698 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g002">Figure 2A</xref>
###xml 810 819 810 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g002">Figure 2B</xref>
###xml 1031 1034 1031 1034 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Giabbai1">[7]</xref>
###xml 1036 1040 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-DeSilva1">[15]</xref>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Park1">[17]</xref>
###xml 1223 1232 1223 1232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g002">Figure 2B</xref>
Lipids found within the sCD1d ligand pool varied in the backbone structure of the lipid and the nature of the lipid head group, and in the numbers, types, chain lengths and degree of unsaturation of the radyl groups. Two major categories of lipids were present: glycerophospholipids and sphingolipids (Figure 2). Within the glycerophospholipid category, three types of radyl group configurations were identified: diradyl species (i.e. containing two carbon chains) were predominant, but monoradyl lyso-phospholipids and tetraradyl cardiolipins were also found (Figure 2A). The diradyl species included common diacylglycerol phospholipids, as well as more unusual reduced forms called plasmalogens (Figure 2A). A variety of polar head groups were found among the glycerophospholipid species in the ligand pool (Figure 2B), including unmodified phosphatidic acid (PA), phosphatidylglycerol (PG), phosphatidylserine (PS), and species that have been previously identified in biochemical analyses as CD1d ligands such as PI, PE, and PC [7], [15]-[17]. Three classes of sphingolipid were also present in the ligand pool: sphingomyelin (SM), and glycosylated sphingolipids (GSL) containing either neutral or acidic modifications (Figure 2B). The sphingolipids included derivatives of sphingosine (i.e. ceramides) as well as forms derived from the structurally related base sphinganine. Notably, we were not able to determine the structures of a number of ions visible on the MS maps. These undetermined species may account for up to one-quarter of the ligand pool.
###end p 13
###begin title 14
Overview of the diversity of lipids identified in the CD1d ligand pool
###end title 14
###begin p 15
###xml 387 396 387 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g001">figure 1A</xref>
. A total of 177 molecular species were identified. The majority of lipids characterized were phospholipids, but sphingolipid species were also identified. A) Tree diagram showing the categories and structural characteristics of lipids found within the ligand pool. B) Tree diagram showing the diversity of lipid head groups. Lipid classes are abbreviated as described in the legend for figure 1A. Numbers in parentheses represents the number of lipid species (i.e. radyl group carbon chain variations) characterized in that subcategory.
###end p 15
###begin title 16
Characteristics of lipid tails
###end title 16
###begin p 17
###xml 752 754 752 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sn</italic>
###xml 827 836 827 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g003">Figure 3A</xref>
###xml 844 846 844 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 926 935 926 935 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g003">Figure 3A</xref>
###xml 938 940 938 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Sn</italic>
###xml 1008 1017 1008 1017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g003">Figure 3B</xref>
###xml 1035 1037 1035 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1053 1055 1053 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1120 1129 1120 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g003">Figure 3B</xref>
###xml 1266 1268 1266 1268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1382 1399 1382 1399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g003">Figures 3A and 3B</xref>
###xml 586 591 <span type="species:ncbi:9606">human</span>
The diversity of lipid head group structures found within the ligand pool is consistent with this feature exerting little influence on selection for binding to CD1d. In contrast, structural characteristics of the radyl groups of lipids are thought to play a major role in lipid binding to CD1 molecules. Previous crystallographic studies have suggested that in order to fit into the A' and C' pockets of CD1d molecules the carbon chains of diacylated lipids should not be longer than C26 and C18, respectively. To gain insight into the characteristics of lipids selected for binding to human CD1d, we analyzed the length and numbers of double bonds of carbon chains from diacylated ligand species. A total of 149 species were included in the analysis. Sn-1 chains ranged from 12-22 carbons and contained from 0-7 double bonds (Figure 3A). Most sn-1 chains (62%) were 16-18 carbons long and contained zero or one unsaturation (Figure 3A). Sn-2 chains ranged from 14-24 carbons and contained 0-6 double bonds (Figure 3B). Similar to the sn-1 chains, most sn-2 chains (58%) were 16-18 carbons with zero or one double bond (Figure 3B). In both cases, there was a tendency for chains longer than 18 carbons to contain at least one double bond, and particularly among the sn-1 chains there was a clear positive correlation between longer chain lengths and higher numbers of double bonds (Figures 3A and 3B).
###end p 17
###begin title 18
Structural characteristics of radyl group carbon chains.
###end title 18
###begin p 19
###xml 307 309 307 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 394 396 394 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 502 504 502 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 514 516 514 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 585 587 585 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 597 599 597 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
Analysis of the length and degree of unsaturation of the carbon chains of diradyl lipid species identified within the ligand pool. The sizes of the circles are proportional to the number of lipid species at each set of coordinates. A total of 149 lipid species were included in the analysis. A) Analysis of sn-1 carbon chains, comparing the number of double bonds to the length. B) Analysis of sn-2 carbon chains, comparing the number of double bonds to the length. C) Comparison of the lengths of the sn-2 versus sn-1 carbon chains. D) Comparison of the number of double bonds in the sn-2 versus sn-1 carbon chains.
###end p 19
###begin p 20
###xml 89 92 89 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Koch1">[9]</xref>
###xml 610 612 610 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 618 620 618 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 707 716 707 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g003">Figure 3C</xref>
###xml 968 977 968 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g003">Figure 3D</xref>
###xml 981 982 981 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 989 991 989 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1113 1122 1113 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g003">Figure 3D</xref>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Based on the sizes of the A' and C' pockets observed in the human CD1d crystal structure [9], it might be predicted that diacylated lipids having both radyl chains longer than 18 carbons would not fit well into the CD1d binding site. Our data is quite consistent with this prediction, since out of 179 species that were molecularly characterized, only four had two chains longer than 18 carbons (i.e. C20:3/C20:3 PA, C20:4/C20:3 PA, C20:3/C20:3 PI, and C20:3/C20:4 PI), and in these cases the chains were only 20 carbons long and all contained 3 or more double bonds. With the exception of these four ligands, sn-1 or sn-2 chains longer than C18 were always paired with chains that were 18 carbons or less (Figure 3C). A comparison of the number of double bonds in each chain revealed that fully saturated lipids were rare in the CD1d ligand pool (4%), and species that contained one double bond in each chain were the most frequent type, comprising 46% of the total (Figure 3D). Sn-1 and sn-2 chains that contained two or more double bonds were usually paired with chains that contained zero or one double bond (Figure 3D).
###end p 20
###begin title 21
Unexpected species: plasmalogens, cardiolipins, and lyso-phospholipids
###end title 21
###begin p 22
###xml 121 124 121 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Giabbai1">[7]</xref>
###xml 126 130 126 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-DeSilva1">[15]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Park1">[17]</xref>
###xml 486 487 486 487 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 490 491 490 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 564 566 564 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 607 608 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 610 611 610 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 623 632 623 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g002">Figure 2A</xref>
###xml 697 701 697 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Brites1">[26]</xref>
###xml 948 956 948 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g004">Figure 4</xref>
###xml 306 311 <span type="species:ncbi:9606">human</span>
Previous biochemical analyses have suggested that common diacylglycerol phospholipids are major cellular ligands of CD1d [7], [15]-[17], but have provided little insight into less common ligands. Our high-resolution analysis permitted identification of a number of interesting but less abundant ligands of human CD1d. For example, we observed that a significant number of plasmalogen derivatives were included among the glycerophospholipids. These compounds contain either an ether (-CH2-CH2-O-) or vinyl ether (-CH = CH-O-) linked to the glycerol backbone at the sn-1 position instead of the usual ester (R1CO2-) linkage (Figure 2A), and are thought play a number of specialized biological roles [26]. Almost half of the PE species characterized fit into this category (21 out of the 43 total species of PE), while plasmalogen forms were uncommon among the other types of glycerophospholipids (1 PA, 1 PC, 1 PS, and 2 PI plasmalogens were found). Figure 4 shows MS/MS results identifying two PE plasmalogen ether species.
###end p 22
###begin title 23
Identification of plasmalogens.
###end title 23
###begin p 24
###xml 296 297 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 392 395 392 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 500 503 500 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 512 515 512 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 704 705 704 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 718 719 718 719 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 721 722 721 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
A fraction of the diradyl phospholipid species within the CD1d ligand pool were identified as plasmalogens, as exemplified by the mass spectrometry data shown here. A) Table summarizing the types of plasmalogen phospholipids identified. B) Negative ion MS/MS of two PE ether plasmalogen species (m/z 726.7), from the MS ion map of Fraction 9. Only the carboxylate ion was characterized. Ions m/z 462 and m/z 444 result from the loss of the 18:1 ketene and the 18:1 carboxylic acid respectively; ions m/z 436 and m/z 418 result from the loss of the 20:2 ketene and the 20:2 carboxylic acid respectively. The molecular formulas for the resulting ether moieties was deduced from the mass of the [M-H-ketene]- and [M-H-RCO2H]- ions. The structures of the ether moieties were not unequivocally determined. They could be plasmenyl or plasmanyl radyl groups.
###end p 24
###begin p 25
###xml 177 186 177 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g002">Figure 2A</xref>
###xml 459 468 459 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g005">Figure 5A</xref>
###xml 480 489 480 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g005">Figure 5B</xref>
Cardiolipins are glycerophospholipids that are abundant in mitochondrial membranes, and are essentially composed of two phosphatidylglycerols linked together at the head group (Figure 2A). As the previously characterized CD1d ligands are mainly diacylated lipids, these tetraradyl compounds may seem unlikely candidates for cellular antigens. However, we found that cardiolipins were present in the CD1d ligand pool, and structurally identified five species (Figure 5A). Shown in Figure 5B is the MS/MS fragmentation pattern of a cardiolipin ion from fraction 18 of the HPLC separation of the CD1d ligand pool.
###end p 25
###begin title 26
Identification of cardiolipins.
###end title 26
###begin p 27
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 299 302 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 315 317 315 317 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8722;</sup>
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 337 339 337 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sub>
###xml 340 342 340 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">29</sub>
###xml 344 345 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 349 352 349 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 367 369 367 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sub>
###xml 370 372 370 372 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sub>
###xml 374 375 374 375 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 376 377 376 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 379 382 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 398 400 398 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sub>
###xml 401 403 401 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sub>
###xml 417 419 417 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2&#8722;</sup>
###xml 421 424 421 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 446 448 446 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 455 457 455 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 504 506 504 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 571 573 571 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
Cardiolipins, which are tetraradyl dimers of phosphatidylglycerol, were present in the CD1d ligand pool. A) Table summarizing the cardiolipin species identified. B) Negative ion MS/MS of ion m/z 713.5 from the MS ion map of Fraction 18, containing cardiolipin (18:1/16:1)/(18:1/18:1). The map shows m/z 713.5 [M-2H]2-, m/z 1173.8 [M-2H-C15H29CO2]-, m/z 1145.8 [M-2H-C17H33CO2]-, m/z 581 [(713.5x2-C16H31CH = C = O)/2]2-, m/z 417 (loss of FA from sn-2 and sn-1 positions of 18:1/18:1 PA structure and the sn-1 position of 18:1/16:1 PA structure), m/z 389 (loss of FA from sn-2 position of 18:1/16:1 PA structure).
###end p 27
###begin p 28
###xml 147 151 147 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Goff1">[14]</xref>
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Roy1">[27]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Chang1">[28]</xref>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Roy1">[27]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Chang1">[28]</xref>
###xml 560 569 560 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g006">Figure 6A</xref>
###xml 572 581 572 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g006">Figure 6B</xref>
###xml 788 790 788 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 916 925 916 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g006">Figure 6C</xref>
###xml 277 283 <span type="species:ncbi:10090">murine</span>
###xml 423 428 <span type="species:ncbi:9606">human</span>
###xml 446 454 <span type="species:ncbi:9606">patients</span>
Recent data has suggested that lipids containing only one hydrocarbon chain may serve as ligands for CD1d, and may thus stimulate T cell responses [14], [27], [28]. A lyso-derivative of the central nervous system lipid sulfatide was found to be recognized by a CD1d-restricted murine T cell line, and lyso-phosphatidylcholine (LPC) was reported to be recognized by CD1d-restricted T cells that are expanded in the blood of human multiple myeloma patients [27], [28]. In this analysis we found a considerable number of lyso-derivatives in the CD1d ligand pool (Figure 6A). Figure 6B shows the MS/MS pattern identifying a species of LPC. The radyl groups of the lyso-derivatives in the CD1d ligand pool showed a similar distribution of carbon chain lengths and double bonds to those of the sn-1 chains of the diacylated lipid species, although carbon chains shorter than C16 were not observed among the lyso- species (Figure 6C).
###end p 28
###begin title 29
Identification of lysophospholipids.
###end title 29
###begin p 30
###xml 187 188 187 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 314 315 314 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 389 390 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 439 442 439 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m/z</italic>
A variety of lyso-phospholipids (i.e. monoradyl species) were found in the CD1d ligand pool. A) Table summarizing the types of lyso-phospholipids identified. B) Negative ion MS/MS of ion m/z 556.5 from ion map of Fraction 36, containing the chloride ion adduct of C18:1/C0:0 PC (lyso-PC or LPC). Ion m/z 556 [M+Cl]-, gives rise to m/z 506 from the neutral loss of chloromethane ([M+Cl]--CH3Cl). The fatty acid 18:1 is indicated by the ion m/z 281. C) Analysis of the carbon chains of the identified lyso-phospholipid species for the number of double bonds compared to chain length.
###end p 30
###begin title 31
Glycosylated lipids
###end title 31
###begin p 32
###xml 102 106 102 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Tsuji1">[29]</xref>
###xml 346 355 346 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g007">Figure 7A</xref>
###xml 622 631 622 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g007">Figure 7B</xref>
###xml 869 878 865 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g007">Figure 7C</xref>
###xml 1103 1112 1099 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g007">Figure 7D</xref>
###xml 1235 1244 1231 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g007">Figure 7E</xref>
Most of the compounds that have been found to be antigens for CD1d-restricted T cells are glycolipids [29]. Thus cellular glycolipids that are presented by CD1d molecules are of great interest. Several glycosylated lipids were identified within the ligand pool, all of which were GSLs containing oligosaccharides attached to a ceramide backbone (Figure 7A). The most abundant of these was identified as a derivative of the ganglioside GM3 by employing MS analysis before and after enzymatic digestion. The MS ion map of fraction 33 from the normal phase HPLC separation of the CD1d ligand pool revealed one major species (Figure 7B). Sialidase S treatment of fraction 33, which specifically releases terminal alpha(2-3)-linked sialic acids from a complex carbohydrate, resulted in the formation of ions produced by the cleavage of sialic acid from the parent compound (Figure 7C). The MS/MS fragmentation pattern of the ion from fraction 33 showed the distinctive initial loss of sialic acid followed by the stepwise loss of two hexoses, and also delineated ions corresponding to the ceramide backbone (Figure 7D). The MS/MS fragmentation pattern after sialidase S treatment showed the same stepwise loss of the remaining two hexoses (Figure 7E). The structural assignment of the ion from fraction 33 as a derivative of GM3 was confirmed by comparing it to the MS/MS fragmentation pattern of a purified GM3 standard (data not shown).
###end p 32
###begin title 33
Identification of glycosylated sphingolipids.
###end title 33
###begin p 34
###xml 149 158 149 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g001">Figure 1A</xref>
###xml 703 704 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 705 706 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 717 718 717 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 790 791 790 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 792 793 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 813 814 813 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 816 817 816 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 818 819 818 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 846 847 846 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 849 850 849 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 851 852 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 880 881 880 881 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 886 887 886 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 888 889 888 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 923 924 923 924 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 926 927 926 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 928 929 928 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 936 938 936 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">26</sub>
###xml 939 941 939 941 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">48</sub>
###xml 943 944 943 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 945 946 945 946 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1029 1030 1029 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">m</italic>
###xml 1031 1032 1031 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 1044 1045 1044 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
Four glycosylated sphingolipid species were identified in the CD1d ligand pool. The most abundant species was identified as the ganglioside GM3 (see Figure 1A). Additionally, three glycosylated ceramides were found. A) Table summarizing the glycosylated lipid ligands identified. B) The most abundant species, fraction 33 of the normal phase HPLC separation, was subject to further characterization by enzymatic digestion and mass spectrometry. Shown is the partial negative ion MS map of fraction 33. C) Partial negative ion MS map of fraction 33 after Sialidase S treatment. Note the formation of ions resulting from the cleavage of sialic acid from the parent compound. D) MS/MS fragmentation of ion m/z 1262 [M-H]- from panel A. The fragmentation pattern shows the loss of sialic acid, m/z 970 [M-sialic acid]-, m/z 808 [M-sialic acid-hexose]-, m/z 790 [M-sialic acid-hexose-H2O]-, m/z 646 [M-sialic acid-hexose-hexose]-, m/z 406 [C26H48NO2]- (N-acyl chain+carbons 1 and 2 of LCB). E) Negative ion MS/MS fragmentation of ion m/z 1006 [M+Cl]- from panel C. The fragmentation pattern shows that after enzymatic cleavage of the sialic acid residue, the remaining two sugar residues are lost in an identical fashion to that of the GM3 species in Panel D.
###end p 34
###begin p 35
###xml 69 78 69 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005325-g007">Figure 7A</xref>
###xml 647 651 647 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Joyce1">[16]</xref>
###xml 635 641 <span type="species:ncbi:10090">murine</span>
###xml 699 704 <span type="species:ncbi:9606">human</span>
###xml 777 782 <span type="species:ncbi:9606">human</span>
Additionally, three neutral GSLs were found in the CD1d ligand pool (Figure 7A). Two of these were assigned as di-hexosylceramides and the third as a tri-hexosylceramide based on their MS/MS fragmentation patterns, which clearly showed the sequential loss of all the hexoses to yield the ceramide (data not shown). We were not able to definitively determine the identities of the sugars found in these GSLs or the chemistry of their linkages. Also undetermined was whether glycosylphosphatidylinositols (GPIs) were present in the ligand pool. A previous analysis identified GPIs as a major constituent of the cellular ligands bound to murine CD1d [16], and thus this may also be a natural ligand of human CD1d molecules. It is worth noting that much of the material within the human CD1d ligand pool that we were not able to identify appeared to be of relatively high molecular weight, and therefore it is possible that more glycosylated ligands are present, and that these may include GPIs.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 175 179 175 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Gumperz2">[30]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Gumperz2">[30]</xref>
###xml 979 983 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Chen1">[31]</xref>
###xml 845 851 <span type="species:ncbi:10090">murine</span>
###xml 885 890 <span type="species:ncbi:9606">human</span>
###xml 963 968 <span type="species:ncbi:9606">human</span>
###xml 1023 1028 <span type="species:ncbi:9606">human</span>
###xml 1232 1237 <span type="species:ncbi:9606">human</span>
Like MHC class I molecules, CD1d molecules are synthesized in the endoplasmic reticulum (ER) and then follow the secretory route through the Golgi and out to the cell surface [30]. However, similar to MHC class II molecules, CD1d molecules are re-internalized from the cell surface and traffic through the endosomal vesicular system before exiting again to the cell surface [30]. Thus, CD1d molecules may acquire ligands in the secretory pathway, or within the endosomal system, or while they are on the cell surface. Since the secreted CD1d molecules that we have analyzed here traffic through the secretory pathway but not through the endosomal vesicular system, the pool of ligands bound to these CD1d molecules may not encompass all of those presented by wild type cell surface CD1d molecules. However, we have found that in contrast to the murine system, endosomal trafficking of human CD1d molecules is not required to stimulate autoreactive responses from human NKT cells [31]. Therefore, antigens that can activate human NKT cells are likely to be present among the cellular CD1d ligands identified in this analysis. Consistent with this, we show in a companion manuscript (see Fox et al., submitted concurrently) that many human NKT cells recognize LPC, a lipid that we show here was present in the CD1d ligand pool.
###end p 37
###begin p 38
###xml 536 545 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005325.s001">Figure S1</xref>
###xml 95 100 <span type="species:ncbi:9606">human</span>
###xml 294 300 <span type="species:ncbi:9913">bovine</span>
###xml 741 746 <span type="species:ncbi:9606">human</span>
It is a concern that non-physiological lipids derived from the culture medium used to grow the human lymphoblastoid cells may load into the secreted CD1d molecules and thus become part of the ligand pool analyzed here. To address this point, we performed an extraction of a sample of the fetal bovine serum (FBS) that is diluted into a nutrient solution to make up the culture medium, and analyzed the lipids by HPLC and MS. The HPLC profile of the FBS lipids showed some peaks that overlapped with those from the CD1d ligand pool (see Figure S1), however MS analysis of fractions containing these peaks did not show any species in common (data not shown). This supports the conclusion that the ligands identified here were derived from the human lymphoblastoid cells used to produce the secreted CD1d molecules.
###end p 38
###begin p 39
###xml 529 532 529 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Zajonc1">[3]</xref>
###xml 533 536 533 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Wu1">[6]</xref>
###xml 538 541 538 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Koch1">[9]</xref>
###xml 928 931 928 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Giabbai1">[7]</xref>
###xml 933 936 933 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Zajonc4">[8]</xref>
###xml 982 984 982 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1054 1056 1054 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1227 1229 1227 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1270 1272 1270 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1593 1595 1593 1595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1602 1604 1602 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1698 1700 1698 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 1706 1708 1706 1708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">sn</italic>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 376 382 <span type="species:ncbi:10090">murine</span>
###xml 386 391 <span type="species:ncbi:9606">human</span>
###xml 951 957 <span type="species:ncbi:10090">murine</span>
###xml 1138 1144 <span type="species:ncbi:10090">murine</span>
By characterizing a large number of molecular species within the CD1d ligand pool, our analysis provides new insights into the structural characteristics of ligands that are selected for binding to human CD1d. One area of interest concerns how the structural features of lipids influence their positioning within the binding site. Crystal structures of sphingolipids bound to murine or human CD1d molecules consistently show that the fatty acyl chain binds in the A' pocket and the sphingosine chain is bound in the C'/F' pocket [3]-[6], [9]. This lipid orientation appears not to be determined by the relative lengths of the two chains, since lipids containing very short fatty acyl chains are positioned in the same orientation as those in which it is longer. However, comparison of the two crystal structures of CD1d molecules containing bound phospholipids suggests that these ligands can bind in either of two orientations [7], [8]. In one case (murine CD1d with bound PC) the sn-1 chain, which is 12 carbons long, is bound in the F' pocket and the sn-2 chain, which is 24 carbons long, is bound in the A' pocket. In the other case (murine CD1d with mannosylated PI) the orientation of the lipid is flipped: the 16 carbon sn-1 chain binds in the A' pocket, and the sn-2 chain, also 16 carbons long, binds in the F' pocket. Assuming that the total hydrocarbon chain length that can fit into the C'/F' pocket is about 18 carbons, our data is consistent with the possibility that phospholipids can bind in either orientation, since lengths greater than 18 carbons were observed for both the sn-1 and sn-2 chains, suggesting that either one can be placed in the larger A' pocket. Moreover, longer sn-1 or sn-2 chains were almost always paired with chains of 18 carbons or less, which is consistent with a requirement for the other chain to fit in the C' pocket. Considering that the orientation of the lipid within the CD1d binding site is likely to affect the positioning of the head group, these data suggest the surprising possibility that a single type of phospholipid might present two different epitopes for TCR recognition depending on the orientation of binding within the CD1d groove.
###end p 39
###begin p 40
###xml 600 604 600 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Brites1">[26]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Gorgas1">[32]</xref>
###xml 146 151 <span type="species:ncbi:9606">human</span>
Another area of interest is the range and diversity of ligand species presented for immune surveillance by CD1d molecules. Our data indicate that human CD1d molecules bind several unexpected types of lipids within the secretory pathway, and these observations have a number of interesting implications. For example, we found that plasmalogen ethers, particularly of PE, accounted for a considerable fraction of the total diacylglycerol phospholipid species. Plasmalogens have been found to play an important role in maintaining proper cellular membrane functioning and in preventing oxidative damage [26], [32]. Because of their ether structure plasmalogens are more acid labile than other glycerophospholipids, and therefore they may be more likely to undergo cleavage within CD1d molecules if transported to acidic endosomal compartments. This might cause them to be more easily removed and replaced by other lipids, or might create new antigenic epitopes if lyso-phospholipid cleavage products remain bound to CD1d.
###end p 40
###begin p 41
###xml 676 680 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Houtkooper1">[33]</xref>
###xml 1163 1167 1163 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Hickman1">[34]</xref>
The finding that cardiolipins were present within the CD1d ligand pool was surprising for two reasons. First, it is not clear how such tetraradyl species would bind to a single CD1d molecule, as the crystallographic data suggest there is only room for two hydrocarbon chains within the binding groove. We speculate that cardiolipins may bind concurrently to two CD1d molecules and thus ligate them together, though further analysis will be required to determine this. The second surprising aspect of this observation is that cardiolipins are confined almost entirely to the inner membrane of the mitochondria where they are synthesized from diacylated precursor phospholipids [33], and therefore their presence in the CD1d ligand pool suggests that they are transported from mitochondria to a location that permits loading into CD1d molecules, such as the ER. Notably, the finding that CD1d molecules may access lipids from mitochondria is consistent with a previous survey of peptide ligands eluted from the MHC class I molecule HLA-B*1801, in which we found that a number of endogenously loaded peptides were derived from proteins localized to the mitochondria [34]. Thus, much like their classical HLA relatives, CD1d molecules survey ligands that originate in diverse intracellular compartments.
###end p 41
###begin p 42
###xml 500 504 500 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-McCarthy1">[11]</xref>
It is also significant that we identified a number of lyso-phospholipids within the CD1d ligand pool. Lyso-phospholipids, particularly LPC, are key signaling molecules generated by enzymatic cleavage of PC by phospholipase A2 molecules, and thus presentation of these molecules by CD1d may serve as an indicator of cellular signaling responses. However, given that the length and structure of the hydrocarbon chains of lipids have been shown to be critical for their stable binding to CD1d molecules [11], and lyso-phospholipids only have a single carbon chain, it is perhaps surprising that that lyso-phospholipids are able to compete effectively with diacylated species for binding to CD1d. Further studies will be required to determine the relative binding affinity of lyso-phospholipids for CD1d, and whether there are specific mechanisms that contribute to the intracellular loading of these lipids.
###end p 42
###begin p 43
###xml 544 548 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Zhou1">[21]</xref>
###xml 694 698 694 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Park2">[35]</xref>
###xml 912 916 908 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Zhou1">[21]</xref>
###xml 1205 1209 1201 1205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Christiansen1">[22]</xref>
###xml 527 533 <span type="species:ncbi:10090">murine</span>
###xml 918 924 <span type="species:ncbi:9606">Humans</span>
###xml 941 945 <span type="species:ncbi:4456">apes</span>
We also found several glycosylated lipids in the ligand pool, including the terminally sialated species GM3. Since maturation of glycans and terminal sialation occur within the Golgi compartments, this finding suggests either that CD1d molecules can load lipid antigens in the Golgi, or that glycans of CD1d-bound ligands can be modified in the Golgi. Interestingly, two of the glycosylated lipids we identified are tri-hexosylated sphingolipids that bear resemblance to iGb3, a compound identified as a major self antigen for murine NKT cells [21]. We identified the major tri-hexosylated species in the ligand pool as GM3, a compound that does not appear to be highly antigenic for NKT cells [35], but the exact identity of the other species remains undetermined. One of the key antigenic features of iGb3 is that the terminal sugar, a galactose, is linked to the next sugar in an alpha-anomeric configuration [21]. Humans and other great apes appear during evolution to have lost the glycosyl transferase enzymes required for biosynthesizing this type of glycan on proteins, and it has recently been demonstrated that we also lack a functional iGb3 synthase gene required to synthesize this glycolipid [22]. Hence, despite its possible structural similarity to iGb3, it seems unlikely that the unidentified tri-hexosylated GSL contains the antigenic feature of a terminal galactose residue in an alpha-linkage.
###end p 43
###begin p 44
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 390 395 <span type="species:ncbi:9606">human</span>
In conclusion, the results presented here demonstrate that natural cellular ligands of human CD1d molecules include a remarkable variety of lipids. In addition to roles in normal cellular functioning, lipids found in the CD1d ligand pool have been specifically associated with immune recognition in disease. Several, including CL, PE, PI, and gangliosides, are targets of autoantibodies in human autoimmune diseases, and cell surface gangliosides on neoplastic cells can also be targeted by specific antibodies. Thus, an important area for future investigation is to understand how the CD1d-mediated presentation of cellular lipids relates to the immunological targeting of these lipids during disease pathogenesis.
###end p 44
###begin title 45
Materials and Methods
###end title 45
###begin title 46
###xml 23 28 <span type="species:ncbi:9606">human</span>
Generation of secreted human CD1d molecules
###end title 46
###begin p 47
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Hickman2">[36]</xref>
###xml 579 583 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Shimizu2">[37]</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 254 257 <span type="species:ncbi:10116">rat</span>
###xml 529 534 <span type="species:ncbi:9606">human</span>
To produce secreted CD1d (sCD1d), the cDNA of human CD1d (Genbank accession number NM_001766) was modified by deleting the transmembrane and cytoplasmic domains, and a 30 base-pair tail encoding the 10 amino acid sequence SVVSTDDDLA corresponding to the rat very low density lipoprotein receptor (VLDLr) was added to facilitate purification [36]. sCD1d-VLDLr was cloned into the mammalian expression vector pcDNA3.1 (Invitrogen) and then sequenced to ensure fidelity. The construct was transfected into the HLA class I deficient human B cell line 721.221 as previously described [37]. Transfectants were cultured in an AcuSyst-Maximizer hollow-fiber bioreactor unit (Biovest International, 8500 Evergreen Boulevard, Minneapolis, MN 55433-6000) in RPMI 1640, 10% FBS and 1% penicillin/streptomycin. Cells were monitored for glucose and oxygen consumption. Supernatants containing approximately 25 mg of sCD1d-VLDLr were collected for further analysis.
###end p 47
###begin title 48
Extraction and purification of bound ligands
###end title 48
###begin p 49
###xml 420 424 420 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Bligh1">[25]</xref>
###xml 677 681 676 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Hax1">[38]</xref>
Clarified supernatant was affinity purified over a Sepharose Fast Flow 4B matrix (Amersham-Pharmacia Biotech, Piscataway, NJ) that was coupled to anti-VLDVr antibody. Bound material was washed with 20 mM sodium phosphate buffer (pH 7.2) and then eluted with 0.2 M acetic acid, pH 2.7, and lyophilized. Ligands were extracted from the CD1d molecules using the chloroform/methanol/water method described by Bligh and Dyer [25]. Lipid classes were separated by normal phase-HPLC (Luna 3 mu Silica (2) 100 A, 150x2 mm column, Phenomenex, Torrance, CA) using a gradient of n-hexane:2-propanol:water (41:54:5 v/v) and n-hexane:2-propanol:water (37:54:9 v/v), as previously described [38]. Fractions of 200 microL were collected at 1.0 min intervals and monitored by UV absorption at 210 nm.
###end p 49
###begin title 50
Mass spectrometric analysis
###end title 50
###begin p 51
###xml 484 488 484 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Hsu1">[39]</xref>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Hsu10">[48]</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Hsu11">[49]</xref>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Hsu13">[51]</xref>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Sorensen1">[52]</xref>
###xml 557 561 557 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Domon1">[55]</xref>
The HPLC fractions were sprayed via nanoESI on a Q-STAR quadrupole mass spectrometer with a TOF detector and nanoESI ionization source (PerSceptive SCIEX, Foster City, CA), generating lipid ion maps for each fraction in the range of 350-2000 amu. Ion maps were obtained in both positive and negative ion modes. Ions were manually selected for MS/MS analyses from these ion maps. Lipid structures were determined with the aid of Lipid Maps () and published MS studies of phospholipids [39]-[48], sphingomyelins and ceramides [49]-[51], and gangliosides [52]-[55]. Representative synthetic lipids corresponding to each class of lipid were purchased from Avanti Polar Lipids (Alabaster, AL) and subjected to MS/MS under identical collision conditions as the naturally occurring lipid.
###end p 51
###begin title 52
Sialidase treatment
###end title 52
###begin p 53
Fraction 33 from the HPLC separation of the CD1d ligand pool was dissolved in aqueous buffer and subject to digestion with sialidase S (Prozyme, San Leandro, CA) according to the manufacturer's protocol. The reaction was then quenched with chloroform, and lipids were extracted from the aqueous phase using chloroform/methanol/water. MS analysis was performed on the organic layer.
###end p 53
###begin title 54
Supporting Information
###end title 54
###begin p 55
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005325-Bligh1">[25]</xref>
###xml 23 29 <span type="species:ncbi:9913">bovine</span>
###xml 43 49 <span type="species:ncbi:9913">bovine</span>
HPLC analysis of fetal bovine serum. Fetal bovine serum (FBS) or a preparation of affinity purified CD1d were organically extracted according to the method of Bligh and Dyer [25]. The resulting material was separated by normal phase HPLC, resulting in the top trace for the CD1d preparation and the bottom trace for the FBS. The fractions from all peaks that overlapped in the two profiles were analyzed by MS. None of the lipids found in the CD1d fractions were detected in FBS fractions of the corresponding peaks (data not shown), indicating that the CD1d lipids did not derive from the FBS.
###end p 55
###begin p 56
(0.24 MB TIF)
###end p 56
###begin p 57
Click here for additional data file.
###end p 57
###begin title 58
References
###end title 58
###begin article-title 59
CD1: Antigen Presentation and T Cell Function.
###end article-title 59
###begin article-title 60
The biology of NKT cells.
###end article-title 60
###begin article-title 61
Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.
###end article-title 61
###begin article-title 62
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity.
###end article-title 62
###begin article-title 63
###xml 22 27 <span type="species:ncbi:10090">mouse</span>
Crystal structures of mouse CD1d-iGb3 complex and its cognate Valpha14 T cell receptor suggest a model for dual recognition of foreign and self glycolipids.
###end article-title 63
###begin article-title 64
Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells.
###end article-title 64
###begin article-title 65
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: a molecular basis for NKT cell activation.
###end article-title 65
###begin article-title 66
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
Structural characterization of mycobacterial phosphatidylinositol mannoside binding to mouse CD1d.
###end article-title 66
###begin article-title 67
###xml 25 30 <span type="species:ncbi:9606">human</span>
The crystal structure of human CD1d with and without alpha-galactosylceramide.
###end article-title 67
###begin article-title 68
Direct measurement of antigen binding properties of CD1 proteins using fluorescent lipid probes.
###end article-title 68
###begin article-title 69
###xml 30 35 <span type="species:ncbi:9606">human</span>
The length of lipids bound to human CD1d molecules modulates the affinity of NKT cell TCR and the threshold of NKT cell activation.
###end article-title 69
###begin article-title 70
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides.
###end article-title 70
###begin article-title 71
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
###end article-title 71
###begin article-title 72
Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.
###end article-title 72
###begin article-title 73
Lipid protein interactions: the assembly of CD1d1 with cellular phospholipids occurs in the endoplasmic reticulum.
###end article-title 73
###begin article-title 74
###xml 18 23 <span type="species:ncbi:10090">mouse</span>
Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol.
###end article-title 74
###begin article-title 75
Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved.
###end article-title 75
###begin article-title 76
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine CD1d-restricted T cell recognition of cellular lipids.
###end article-title 76
###begin article-title 77
Mechanism of CD1d-restricted natural killer T cell activation during microbial infection.
###end article-title 77
###begin article-title 78
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human CD1-restricted T cell recognition of lipids from pollens.
###end article-title 78
###begin article-title 79
Lysosomal glycosphingolipid recognition by NKT cells.
###end article-title 79
###begin article-title 80
###xml 0 6 <span type="species:ncbi:9606">Humans</span>
Humans lack iGb3 due to the absence of functional iGb3-synthase: implications for NKT cell development and transplantation.
###end article-title 80
###begin article-title 81
###xml 19 24 <span type="species:ncbi:9606">human</span>
###xml 88 93 <span type="species:ncbi:9606">human</span>
Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells.
###end article-title 81
###begin article-title 82
Large-scale production of class I bound peptides: assigning a signature to HLA-B*1501.
###end article-title 82
###begin article-title 83
A rapid method of total lipid extraction and purification.
###end article-title 83
###begin article-title 84
Functions and biosynthesis of plasmalogens in health and disease.
###end article-title 84
###begin article-title 85
Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
###end article-title 85
###begin article-title 86
###xml 84 89 <span type="species:ncbi:9606">human</span>
Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer.
###end article-title 86
###begin article-title 87
Glycolipids and phospholipids as natural CD1d-binding NKT cell ligands.
###end article-title 87
###begin article-title 88
The ins and outs of CD1 molecules: bringing lipids under immunological surveillance.
###end article-title 88
###begin article-title 89
###xml 101 106 <span type="species:ncbi:9606">human</span>
Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules.
###end article-title 89
###begin article-title 90
###xml 26 31 <span type="species:ncbi:10090">mouse</span>
The ether lipid-deficient mouse: tracking down plasmalogen functions.
###end article-title 90
###begin article-title 91
Cardiolipin, the heart of mitochondrial metabolism.
###end article-title 91
###begin article-title 92
Toward a definition of self: proteomic evaluation of the class I peptide repertoire.
###end article-title 92
###begin article-title 93
Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.
###end article-title 93
###begin article-title 94
C-terminal epitope tagging facilitates comparative ligand mapping from MHC class I positive cells.
###end article-title 94
###begin article-title 95
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 104 109 <span type="species:ncbi:9606">human</span>
Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line.
###end article-title 95
###begin article-title 96
High-performance liquid chromatographic separation and photometric detection of phospholipids.
###end article-title 96
###begin article-title 97
Differentiation of 1-O-alk-1'-enyl-2-acyl and 1-O-alkyl-2-acyl glycerophospholipids by multiple-stage linear ion-trap mass spectrometry with electrospray ionization.
###end article-title 97
###begin article-title 98
###xml 137 148 <span type="species:ncbi:3702">Arabidopsis</span>
Electrospray ionization multiple stage quadrupole ion-trap and tandem quadrupole mass spectrometric studies on phosphatidylglycerol from Arabidopsis leaves.
###end article-title 98
###begin article-title 99
###xml 37 53 <span type="species:ncbi:562">Escherichia coli</span>
Characterization of cardiolipin from Escherichia coli by electrospray ionization with multiple stage quadrupole ion-trap mass spectrometric analysis of [M-2H+Na]- ions.
###end article-title 99
###begin article-title 100
Studies on phosphatidylserine by tandem quadrupole and multiple stage quadrupole ion-trap mass spectrometry with electrospray ionization: structural characterization and the fragmentation processes.
###end article-title 100
###begin article-title 101
###xml 51 73 <span type="species:ncbi:90371">Salmonella typhimurium</span>
Characterization of acylphosphatidylglycerols from Salmonella typhimurium by tandem mass spectrometry with electrospray ionization.
###end article-title 101
###begin article-title 102
Electrospray ionization/tandem quadrupole mass spectrometric studies on phosphatidylcholines: the fragmentation processes.
###end article-title 102
###begin article-title 103
Characterization of alkylacyl, alk-1-enylacyl and lyso subclasses of glycerophosphocholine by tandem quadrupole mass spectrometry with electrospray ionization.
###end article-title 103
###begin article-title 104
Characterization of phosphatidylinositol, phosphatidylinositol-4-phosphate, and phosphatidylinositol-4,5-bisphosphate by electrospray ionization tandem mass spectrometry: a mechanistic study.
###end article-title 104
###begin article-title 105
Charge-remote and charge-driven fragmentation processes in diacyl glycerophosphoethanolamine upon low-energy collisional activation: a mechanistic proposal.
###end article-title 105
###begin article-title 106
Charge-driven fragmentation processes in diacyl glycerophosphatidic acids upon low-energy collisional activation. A mechanistic proposal.
###end article-title 106
###begin article-title 107
Characterization of ceramides by low energy collisional-activated dissociation tandem mass spectrometry with negative-ion electrospray ionization.
###end article-title 107
###begin article-title 108
Structural studies on ceramides as lithiated adducts by low energy collisional-activated dissociation tandem mass spectrometry with electrospray ionization.
###end article-title 108
###begin article-title 109
Structural determination of sphingomyelin by tandem mass spectrometry with electrospray ionization.
###end article-title 109
###begin article-title 110
###xml 112 118 <span type="species:ncbi:9913">bovine</span>
###xml 128 134 <span type="species:ncbi:9606">infant</span>
A liquid chromatography/tandem mass spectrometric approach for the determination of gangliosides GD3 and GM3 in bovine milk and infant formulae.
###end article-title 110
###begin article-title 111
###xml 83 88 <span type="species:ncbi:9606">human</span>
Nano-electrospray ionization time-of-flight mass spectrometry of gangliosides from human brain tissue.
###end article-title 111
###begin article-title 112
Anencephaly: structural characterization of gangliosides in defined brain regions.
###end article-title 112
###begin article-title 113
Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry.
###end article-title 113
###begin p 114
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 114
###begin p 115
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: Major funding for this project was provided by the Office of the Provost, The University of Oklahoma Health Sciences Center, and by National Institutes of Health Contract HHSN266200400027C. Additional funding was from NIH grants R01 HL071590 and R01AI074940. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 115

